Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Glycididazole with Chemoradiotherapy for Esophageal Squamous Cell Carcinoma
NCT02721563Phase 4Completed
- Sponsor
- Shandong Cancer Hospital
- Start
- Feb 2016
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sodium glycididazole in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by Shandong Cancer Hospital. Started Feb 2016; status: completed.
02
Drugs
sodium glycididazole
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT02721563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02721563.